Without finding that paragraph 5.2 was a legally binding interpretation under Article IX:2, the panel determined that it must "guide" the panel's interpretation of "reasonable interval." 22 In the alternative, the panel found that paragraph 5.2 could be considered a subsequent agreement of the parties within Article 31(3) of the Vienna Convention on the Law of Treaties (Vienna Convention)
Products will be required to undergo a lengthy (years long), prohibitively expensive (hundreds of thousands to millions of dollars per product) and onerous process for pre-market approval from the FDA, with no certainty or any demonstrated likelihood of success
And it's cute because of its shape, hehe
In August, the American Lung Association, the American Academy of Pediatrics and several other US health organizations urged the FDA to act against these online loopholes, calling their failure to do so an unlawful withholding of agency action. Carr said some policy changes could help restrict young peoples access to these products
"A number of other countries are examining the policy," the WHO added
